16
4
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T14337 |
Buloxibutid
AT2 receptor agonist C21 |
RAAS | Endocrinology/Hormones |
Buloxibutid (AT2 receptor agonist C21) 是一种新型且具有选择性小分子 angiotensin II AT2 receptor (血管紧张素 II AT2 受体)激动剂,对 AT2 受体和 AT1 受体的 Ki 值分别为 0.4 nM 和 10 μM。 | |||
T71805 |
DOCK5-IN-C21
|
||
DOCK5-IN-C21 is an allosteric inhibitor of the guanine nucleotide exchange factor DOCK5. | |||
TP2041 |
C 21
|
||
Selective protein arginine methyltransferase 1 (PRMT1) inhibitor (IC50 = 1.8 μM). Exhibits five-fold selectivity for PRMT1 over PRMT6 and >250-fold selectivity over PRMT3 and CARM1. | |||
T11096 |
DRI-C21045
|
NF-κB | NF-κB |
DRI-C21045 是一种有效的 CD40-CD40L 协同刺激蛋白-蛋白质相互作用的选择性抑制剂,IC50 为 0.17 μM。它显示对 CD40L 诱导的 NF-κB 活化和 B 细胞增殖的浓度依赖性抑制,IC50分别为 17.1 μM 和 4.5 μM。 | |||
T7398 |
ONC212
|
Apoptosis; GPR | Apoptosis; Endocrinology/Hormones; GPCR/G Protein |
ONC212 是氟化 ONC201 类似物,是有前景的抗癌剂。它也是 GPR132的选择性激动剂,可诱导凋亡。 | |||
T9314 |
CC214-1
|
mTOR; Autophagy | Autophagy; PI3K/Akt/mTOR signaling |
CC214-1 是一种 mTOR 抑制剂,具有潜在的抗癌活性,抑制蛋白翻译,可诱导自噬 (autophagy)。 CC214-1 是探索 mTOR 激酶生物学的体外工具化合物,可用于研究骨髓瘤。 | |||
T50080 |
MC2184
|
Sirtuin | Chromatin/Epigenetic; DNA Damage/DNA Repair |
MC2184 是人重组 SIRT1 的抑制剂。 | |||
T8318 |
BNC210
H-Ile-Trp-OH,IW-2143 |
AChR | Neuroscience |
BNC210 (IW-2143) 是一种α7 nAChR 负变构调节剂,在焦虑和抑郁动物模型中有活性。 | |||
T78198 | DRI-C21041 (DIEA) | ||
DRI-C21041 (DIEA)是一种IC50值为0.31 μM的CD40/CD40L相互作用抑制剂,能够抑制同种异体抗原诱导的免疫反应。 | |||
T70992 | NVP-CFC218 | ||
NVP-CFC218 is a novel potent and selective p53-HDM2 inhibitor. | |||
T61659 |
CC214-2
|
||
CC214-2 is a potent dual inhibitor of mTORC1 and mTORC2, known for its ability to impede autophagy by modulating mammalian target of rapamycin (mTOR) signaling. With this capacity, CC214-2 shows promise in shortening the duration of tuberculosis (TB) [1]. | |||
T26289 |
TRC210258
TRC-210258,TRC 210258 |
||
TRC210258 is a TGR5 agonist that acts by decreasing glycemic and dyslipidemic cardiovascular risk in animal models of diabesity. | |||
T82954 | ATAC21 | ||
ATAC21是一种连接子免疫刺激化合物,它通过含琥珀酰亚胺基团的稳定型马来酰亚胺-PEG4连接子与免疫刺激化合物结合而成。ATAC21能够与SBT-040(抗CD40抗体)结合,形成具有免疫激活作用的偶联物。 | |||
T79193 | DRI-C21041 | ||
DRI-C21041,作为一种针对CD40/CD40L相互作用的抑制剂,其IC50为0.31 μM,能够抑制由同种异体抗原诱导的免疫反应。 | |||
T68513 |
BSc2118
|
||
BSc2118 is a potent proteasome inhibitor. BSc2118 shows significant antimyeloma activity and may be considered as a promising agent in cancer drug development. BSc2118 is also a promising new candidate for stroke therapy, which may in addition alleviate recombinant tissue-plasminogen activator-induced brain toxicity. | |||
T32465 |
L 685818
L 685,818,L685,818,L685818,L-685,818,L-685818 |
||
L 685818 is the C18-hydroxy, C21-ethyl of FK-506 analog. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T5223 |
Heneicosanoic acid
二十一碳酸,Heneicosylic Acid,C21:0 |
Others; Endogenous Metabolite | Metabolism; Others |
Heneicosanoic acid (C21:0) 是广泛存在于动植物中的长链饱和脂肪酸。 | |||
T7024 |
Qingyangshengenin
青阳参甙元,Qingyangshengenin A,Cynanchagenin |
Others | Others |
Qingyangshengenin (Cynanchagenin) 是一种孕烷糖苷,是一种分离自Cychuchumot ophyllum(Asclepiadaceae) 的根中的 C21 类固醇糖苷配基。它具有抗癌作用。 | |||
T6S1842 |
Tenacissoside G
Tenacissimoside A,通关藤苷G |
Others | Others |
Tenacissoside G 是一种 C21 甾体,来自于Marsdenia tenacissima 茎部。它可逆转 P-糖蛋白过度表达的多药耐药癌细胞的多药耐药。 | |||
T6S1843 |
Tenacissoside I
通关藤苷I,Tenacissimoside B |
Others | Others |
Tenacissoside I (Tenacissimoside B) 是一种 C21 甾体,来自于Marsdenia tenacissima 中,在M. tenacissima 含量较高。 |